We investigated the genetic polymorphisms of CYP1A1, CYP2E1 and GSTM1 in Japanese esophageal cancer patients (n = 53) with a histological diagnosis of squamous-cell carcinoma, to determine whether susceptibility to esophageal cancer is associated with these polymorphisms. There were no significant d
Polymorphisms inGSTM1,CYP1A1,CYP2E1, andCYP2D6are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer Patients
โ Scribed by WeiYing Li; WenTao Yue; LiNa Zhang; XiaoTing Zhao; Li Ma; XueHui Yang; ChunYan Zhang; Yue Wang; Meng Gu
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 218 KB
- Volume
- 190
- Category
- Article
- ISSN
- 0341-2040
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. The authors investigated whether __ABCB1, ABCC2,__ and __ABCG2__ genetic polymorphisms affect pharmacokinetics (PK) of irinotecan and treatment outcome of patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Blood samples from 107 NSCLC patients treate
The records of 65 consecutive patients with non-small-cell lung cancer (NSCLC) treated with intensive induction chemotherapy were reviewed to study the infectious complications during therapy and to analyze the relationship of the frequency of infections to various predisposing factors. A total of 4